The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
CVS Triple Antibiotic
Bacitracin, Neomycin, Polymyxin B · BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g · Ointment · Topical · CVS Pharmacy
NDC 69842-0610-71 · 1 BOTTLE in 1 PACKAGE / 7.7 g in 1 BOTTLE · OTC MONOGRAPH FINAL · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- part333B
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Bacitracin, Neomycin, Polymyxin B (Ointment)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| CVS Pharmacy | BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "CVS Triple Antibiotic — NDC 69842-0610-71," retrieved September 3, 2026, https://drugdashboards.com/drug/69842061071.
Free to cite with attribution — see how the data is put together.